I expect TLON.OB to finish north of its recent high of $1.26/share by the end of this week. That will be a prelude to a positive FDA decision as it applies to Marqibo. Once approved, these shares will head north and bust through the high of $1.65/share as recorded on April 29, 2011. Watching this stock soar through and beyond that point should provide plenty of entertainment for those who now call themselves shareholders. TLON.OB will be a short term and long term money maker. I give it a "strong buy" at this time.